Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 2
1973 11
1974 8
1975 14
1976 11
1977 9
1978 5
1979 14
1980 9
1981 26
1982 3
1983 13
1984 32
1985 19
1986 24
1987 43
1988 31
1989 36
1990 50
1991 70
1992 43
1993 61
1994 96
1995 91
1996 109
1997 107
1998 143
1999 140
2000 113
2001 123
2002 112
2003 117
2004 117
2005 122
2006 124
2007 139
2008 141
2009 153
2010 163
2011 169
2012 196
2013 195
2014 208
2015 216
2016 219
2017 226
2018 223
2019 141
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

4,053 results
Results by year
Filters applied: . Clear all
Page 1
Niraparib: A Review in Ovarian Cancer.
Heo YA, Duggan ST. Heo YA, et al. Target Oncol. 2018 Aug;13(4):533-539. doi: 10.1007/s11523-018-0582-1. Target Oncol. 2018. PMID: 30073633 Review.
A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee.
Deshmukh V, Hu H, Barroga C, Bossard C, Kc S, Dellamary L, Stewart J, Chiu K, Ibanez M, Pedraza M, Seo T, Do L, Cho S, Cahiwat J, Tam B, Tambiah JRS, Hood J, Lane NE, Yazici Y. Deshmukh V, et al. Osteoarthritis Cartilage. 2018 Jan;26(1):18-27. doi: 10.1016/j.joca.2017.08.015. Epub 2017 Sep 6. Osteoarthritis Cartilage. 2018. PMID: 28888902 Free article.
Niraparib for the treatment of ovarian cancer.
Essel KG, Moore KN. Essel KG, et al. Expert Rev Anticancer Ther. 2018 Aug;18(8):727-733. doi: 10.1080/14737140.2018.1490180. Epub 2018 Jul 2. Expert Rev Anticancer Ther. 2018. PMID: 29911447 Review.
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers.
Villa GR, Hulce JJ, Zanca C, Bi J, Ikegami S, Cahill GL, Gu Y, Lum KM, Masui K, Yang H, Rong X, Hong C, Turner KM, Liu F, Hon GC, Jenkins D, Martini M, Armando AM, Quehenberger O, Cloughesy TF, Furnari FB, Cavenee WK, Tontonoz P, Gahman TC, Shiau AK, Cravatt BF, Mischel PS. Villa GR, et al. Cancer Cell. 2016 Nov 14;30(5):683-693. doi: 10.1016/j.ccell.2016.09.008. Epub 2016 Oct 13. Cancer Cell. 2016. PMID: 27746144 Free PMC article.
Niraparib: First Global Approval.
Scott LJ. Scott LJ. Drugs. 2017 Jun;77(9):1029-1034. doi: 10.1007/s40265-017-0752-y. Drugs. 2017. PMID: 28474297
Mechanism of antineoplastic activity of lonidamine.
Nath K, Guo L, Nancolas B, Nelson DS, Shestov AA, Lee SC, Roman J, Zhou R, Leeper DB, Halestrap AP, Blair IA, Glickson JD. Nath K, et al. Biochim Biophys Acta. 2016 Dec;1866(2):151-162. doi: 10.1016/j.bbcan.2016.08.001. Epub 2016 Aug 4. Biochim Biophys Acta. 2016. PMID: 27497601 Free PMC article. Review.
A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.
Yazici Y, McAlindon TE, Fleischmann R, Gibofsky A, Lane NE, Kivitz AJ, Skrepnik N, Armas E, Swearingen CJ, DiFrancesco A, Tambiah JRS, Hood J, Hochberg MC. Yazici Y, et al. Osteoarthritis Cartilage. 2017 Oct;25(10):1598-1606. doi: 10.1016/j.joca.2017.07.006. Epub 2017 Jul 13. Osteoarthritis Cartilage. 2017. PMID: 28711582 Free article. Clinical Trial.
4,053 results
Jump to page
Feedback